![Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease The NIHR Funded PATHWAY Research Programme](https://www.adept-ru.com/wp-content/uploads/2022/11/Evaluating-Metacognitive-Therapy-to-Improve-Treatment-of-Anxiety-and-Depression-in-Cardiovascular-Disease-The-NIHR-Funded-PATHWAY-Research-Programme.png)
Wells, A., Reeves, D., Heal, C., Davies, L. M., Shields, G. E., Heagerty, A., … & Capobianco, L. (2022). Evaluating metacognitive therapy to improve treatment of anxiety and depression in cardiovascular disease: the NIHR funded pathway research programme. Frontiers in psychiatry, 13, 886407.
Background: One in three cardiovascular disease (CVD) patients experience significant anxiety and depression. Current psychological interventions have limited efficacy in reducing such symptoms and are offered as a face-to-face intervention that may be a barrier to accessing treatment. We evaluated the feasibility and acceptability of delivering assisted home-based self-help metacognitive therapy (home-MCT) to cardiac rehabilitation (CR) patients experiencing anxiety and depression.